PET emerges as staging exam for cervical cancer

July 1, 2008 Diagnostic Imaging. PET emerges as staging exam for cervical cancer By Shalmali Pal -------------------------------------------------------------------------------- Preliminary study establishes PET/CT effectiveness for evaluating cancer after a negative CT finding Surgery has been the standard for cervical cancer staging for more than three decades, despite leading to complications, especially when followed by radiation therapy. Evidence continues to accumulate, however, indicating that PET studies may be up to the pretreatment challenge presented by the second leading cause of cancer mortality in women worldwide. "Since the first reports of FDG-PET in patients with cervical cancer were published 10 years ago, the role of functional imaging in this disease has rapidly expanded," said Dr. Michael Gold, chair of the ongoing Gynecologic Oncology Group (GOG 233/ACRIN 6671) study on the utility of cervical cancer treatment planning with PET/CT and MRI (J Natl Compr Canc Netw 2008;6[1]:37-45).

See full article and related articles at DiagnosticImaging.com
This article was republished with permission from CMPMedica, LLC